Inhibikase Therapeutics Long Term Debt Current 2011-2026 | IKT

Annual Long Term Debt Current Inhibikase Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	150 K	146 K	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
150 K	146 K	148 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	57.6 K	$ 3.97	6.43 %	$ 9.55 B	Australia
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
AlloVir ALVR	316 K	-	4.14 %	$ 49.1 M	USA
Aligos Therapeutics ALGS	3.58 M	$ 7.66	3.23 %	$ 75.7 M	USA
Allakos ALLK	3.25 M	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	45.5 M	$ 320.13	-3.98 %	$ 41.9 B	USA
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
Amphastar Pharmaceuticals AMPH	7.93 M	$ 21.81	0.6 %	$ 1.02 B	USA
Applied Therapeutics APLT	429 K	-	-	$ 8.42 M	USA
BioNTech SE BNTX	45 M	$ 102.12	2.66 %	$ 27.2 B	Germany
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	2.2 M	-	-13.39 %	$ 1.45 M	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	215 K	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	43 K	$ 3.08	-4.94 %	$ 5.07 M	Israel
AgeX Therapeutics AGE	181 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	3.55 M	$ 1.35	-12.9 %	$ 347 M	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	631 K	$ 4.26	0.47 %	$ 456 M	USA
AstraZeneca PLC AZN	382 M	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	294 K	$ 24.19	-1.59 %	$ 3.08 B	USA
AIkido Pharma AIKI	554 K	-	1.93 %	$ 17.4 M	USA
Brainstorm Cell Therapeutics BCLI	208 K	-	-2.5 %	$ 5.88 M	USA
Autolus Therapeutics plc AUTL	4.56 M	$ 1.61	8.05 %	$ 428 M	Britain
Aptose Biosciences APTO	193 K	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	878 K	-	1083.1 %	$ 745 M	USA
BeiGene, Ltd. BGNE	20.7 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	21.2 M	-	-	$ 546 M	USA
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
Cidara Therapeutics CDTX	1.38 M	-	-	$ 1.41 B	USA
BioXcel Therapeutics BTAI	65 K	$ 1.07	1.9 %	$ 13.1 M	USA
Cabaletta Bio CABA	3.46 M	$ 3.52	3.53 %	$ 354 M	USA
CymaBay Therapeutics CBAY	7 K	-	-	$ 3.45 B	USA
Allena Pharmaceuticals ALNA	317 K	-	3.16 %	$ 1.9 M	USA
ChromaDex Corporation CDXC	1 M	-	-0.88 %	$ 598 M	USA